Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy-Reference-Cited by-同舟云学术

Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy

Published:2019-05-17 Issue:15 Volume:79 Page:3940-3951
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Zhang Qiang,Green Michael D.^ORCID,Lang Xueting,Lazarus Jenny,Parsels Joshua D.,Wei Shuang,Parsels Leslie A.,Shi Jiaqi^ORCID,Ramnath Nithya,Wahl Daniel R.,Pasca di Magliano Marina,Frankel Timothy L.,Kryczek Ilona,Lei Yu L.,Lawrence Theodore S.,Zou Weiping,Morgan Meredith A.

Funder

Roger and Gloria DeMeritt Pancreatic Cancer Research

Cancer Center Support

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The crosstalk between DNA-damage responses and innate immunity;International Immunopharmacology;2024-10

2. Kaempferol from Alpinia officinarum hance induces G2/M cell cycle arrest in hepatocellular carcinoma cells by regulating the ATM/CHEK2/KNL1 pathway;Journal of Ethnopharmacology;2024-10

3. Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies;Cancer Treatment Reviews;2024-09

4. Loss of the DNA repair protein, polynucleotide kinase/phosphatase, activates the type 1 interferon response independent of ionizing radiation;Nucleic Acids Research;2024-08-01

5. Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells;International Journal of Molecular Sciences;2024-07-16